Research & Development: Page 44

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    In this month’s Forum, experts from multiple disciplines, from drug development to marketing, discuss the challenges and opportunities that technology is bringing to the table. AstraZeneca’s CIO David Smoley sums up the changing landscape neatly: “When it comes to IT, we cannot operate in a world...

    By Taren Grom • May 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Industry at Large AbbVie To Award 40 CF Scholarships AbbVie has announced the 2015 AbbVie CF Scholarship, which honors and supports young adults with cystic fibrosis (CF) as they pursue higher education, is now open to undergraduate and graduate students. For the 23rd year, the AbbVie CF Scholar...

    By PharmaVoice Team • May 1, 2015
  • cancer healthcare Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Oncology

    As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Automating Medicinal Chemistry Through Building Blocks Martin Burke, M.D., Ph.D., and Mark Goldsmith, M.D., Ph.D., founded Revolution Medicines, which has an automated chemical synthesis platform that can be used to produce a broad range of molecules. Through the years of trial and error, researc...

    By PharmaVoice Team • May 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    Turing Pharmaceuticals New Drug Company Launched Trending now: Experienced team comes together to focus on treating unmet medical needs. Turing Pharmaceuticals, a new pharmaceutical company, launched with news of three acquisitions for its commercial operations and development pipeline. New York-...

    By PharmaVoice Team • May 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Trax

    Cancer Care in America: A Shifting Landscape Trending now: Amid growing patient demand and administrative burden, there are stresses on the oncology care system. The U.S. cancer care system faces tremendous turbulence while dealing with growing numbers of cancer patients and survivors, mounting ...

    By PharmaVoice Team • May 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    Coming Attractions DIA 2015, the 51st annual meeting, is the largest multidisciplinary event that brings together a global network of life-sciences professionals to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.  This year’s t...

    By PharmaVoice Team • May 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Biopharma Pool Steven Ertel Dr. Matthew Sherman Acceleron Pharma Announces Executive Appointments and Promotions Acceleron Pharma, a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic candidates that regulate cellular growth...

    By PharmaVoice Team • May 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Enabling Cancer Immunotherapies Henry Li, Ph.D., VP, Translational Oncology at Crown Bioscience, talks about the challenges of developing new and novel cancer immunotherapeutics. PV: Cancer immunotherapy is a hot area of research now. Why do you think this is? Li: Cancer chemotherapies are toxic ...

    By Henry Li • May 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    3D Applications in Medicine

    Three-dimensional printing is no longer simple plastic prototypes. Today, 3-D printers can produce fully functional components, including complex mechanisms, batteries, transistors, and LEDs. 3D printing — also known as additive manufacturing — is the process of making three-dimensional solid obj...

    By Denise Myshko • May 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Early Cancer Detection

    For most cancers, diagnosis happens too late, when the cancer has worsened or metastasized. But when cancers are diagnosed early, survival statistics are much higher. For example, the five-year survival rate for patients diagnosed with colorectal cancer is around 90% if diagnosed when the cancer ...

    By Denise Myshko • May 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    2015 HBA Luminaries

    The Importance of Mentoring and Sponsorship Emily Lightfoot. AmerisourceBergen. Relationships with mentors have been the key to my career success. Having an advocate and coach to help me plan my career, discover my strengths, and identify opportunities has helped me develop confidence to take on ...

    By Taren Grom • May 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Biotechnology Pool Mary Thistle Dimension Names Chief Business Officer Dimension Therapeutics, a rare disease company advancing novel treatments for diverse genetic disorders of the liver based upon an AAV gene therapy platform, has appointed Mary Thistle to the newly created position of chief bu...

    By PharmaVoice Team • April 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    A New Way to KILL INFECTIONS Mark Offerhaus, Chief Executive of the Dutch firm Micreos, talks about the company’s antibiotic alternative that uses endolysins. Antibiotic resistance is increasingly becoming a serious global threat to public health and is the cause of many common infections, includ...

    By Mark Offerhaus • March 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Trax

    Putting the “e" in Patient-Reported Outcomes Trending now: Electronic data collection improves data quality, shortens study timelines, and increases the likelihood of regulatory approval. Although transitioning from a pen-and-paper strategy to an electronic patient-reported outcome (ePRO) approac...

    By PharmaVoice Team • March 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Biotechnology Pool Tony Hunt Repligen Names CEO Repligen, a life-sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs, has appointed Tony Hunt as CEO. Mr. Hunt, currently Repligen’s chief operatin...

    By PharmaVoice Team • March 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive appointments and promotions in the healthcare industry Pharma Pool Dr. Julie Gerberding Merck Strengthens Executive Team Merck has named Julie Gerberding, M.D., as executive VP for strategic communications, global public policy and population health. In this newly created executive comm...

    By PharmaVoice Team • Feb. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Addressing the Needs of THOSE WITH RARE DISEASES Peter Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), talks about recent orphan drug approvals. PV: 2014 was a record year for orphan drug approvals. What are your predictions for the orphan drug space for 201...

    By Peter Saltonstall • Feb. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A New Frontier: Bioelectronics Medicines

    The nervous system is essentially the body’s electrical and communication system that wires together all the nerves and organs — starting at the brain and central cord and branching out to every other part of the body. Technological advances have led researchers to consider how the nervous system...

    By Denise Myshko • Feb. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE FEATURE: Outsourcing: Outsourcing in a New Era

    Companies continue to examine new ways to optimize operations and capitalize on efficiencies through partnerships. As the industry continues to move to a more patient-centric model, which encompasses all aspects of the continuum from R&D through commercialization, CROs and other service partn...

    By Taren Grom • Feb. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive appointments and promotions in the healthcare industry Pharma Pool Stephen Aselage Retrophin Appoints CEO Retrophin has appointed Stephen Aselage as CEO; he has served as the company’s interim CEO since Sept. 30, 2014. Mr. Aselage has more than 30 years of pharmaceutical and biotechnolo...

    By PharmaVoice Team • Jan. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    C-Suite: Clinical Services

    We asked C-suite executives throughout the clinical services ecosystem to provide their insights on what the biggest opportunities for innovation are, what the biggest barriers are, and identify a recent innovation that is improving the process. Dr. Martine Dehlinger-Kremer Global VP, Medical an...

    By Taren Grom • Jan. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    R&D Crowdsourcing: Crowdsourcing in Pharma

    Companies are looking at nontraditional ways of collaborating to access new insights that could lead to innovative therapies. There is a growing movement within the industry toward open access and crowdsourcing scientific information to accelerate research and development. This open environment r...

    By Denise Myshko • Nov. 15, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Augmented Reality: An Overlap Between the Virtual and the Real World

    Augmented reality can take technology to a new level to improve patient outcomes and the healthcare journey. Augmented reality, the technology originally popularized as part of simulators and virtual reality games more than a decade ago, is gaining traction today in the pharma space. AR is relate...

    By Taren Grom • Nov. 15, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Power of the Patient: The Era of Healthcare Consumerism

    The step-change towards healthcare consumerism means that healthcare providers are increasingly targeting their products towards patients to help them become more engaged in their own healthcare decision-making along their journey as a patient, focusing on quality and convenience. With this in mi...

    By Tim Davis • Nov. 15, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Healthcare Storytelling Delivery: In the Digital Age

    If you represent a brand, you must tell a story about the features and benefits of your project, so that your target user can make sense of it. Yesterday, a woman named Sharon dragged herself out of bed and shuffled to the shower. She turned on the water and massaged shampoo into her hair. And as...

    By Buddy Scalera • Nov. 15, 2014